Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Crohn Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Crohn's & Colitis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial
J Crohns Colitis 2021 Aug 17;[EPub Ahead of Print], S Vermeire, G D'Haens, F Baert, S Danese, T Kobayashi, EV Loftus, S Bhatia, C Agboton, M Rosario, C Chen, W Zhang, K Kisfalvi, WJ SandbornFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.